Penstabil mastosit

Category of pharmaceutical drugsTemplat:SHORTDESC:Category of pharmaceutical drugs

Penstabil mastosit atau penstabil sel mast adalah medikasi yang digunakan untuk mencegah atau mengobati gangguan alergi tertentu. Obat ini memblokir degranulasi sel mast, menstabilkannya dan dengan demikian mencegah pelepasan histamin dan mediator terkait. Salah satu mekanisme farmakodinamik yang diduga adalah pemblokiran saluran kalsium yang diatur IgE. Tanpa kalsium intraseluler, vesikel histamin tidak dapat menyatu dengan membran sel dan mengalami degranulasi.^[1]

Sebagai inhaler, obat ini digunakan untuk mengobati asma, sebagai semprotan hidung untuk mengobati rinitis alergi dan sebagai tetes mata untuk konjungtivitis alergi.^[2] Dalam bentuk oral, obat ini digunakan untuk mengobati suatu kondisi langka yakni mastositosis.^[3]^[4]

Contoh

Medikasi penstabili mastosit termasuk:

Asam kromoglikat (kromolin/kromoglikat)^[5]^[6]^[1]^[7]^[4]
ketotifen^[1]^[7]^[8]^[9]
lodoksamida^[4]^[10]
nedokromil^[10]^[11]
pemirolast^[4]
olopatadin^[12]

Penelitian

Zat-zat berikut ini diteliti mengenai potensi efeknya dalam menstabilkan sel mast, namun hasil penelitian saat ini masih belum meyakinkan:

Referensi

1 2 3 Finn DF, Walsh JJ (September 2013). "Twenty-first century mast cell stabilizers". Br J Pharmacol. 170 (1): 23–37. doi:10.1111/bph.12138. PMC 3764846. PMID 23441583.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
↑ Castillo M, Scott NW, Mustafa MZ, Mustafa MS, Azuara-Blanco A (2015). "Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis". Cochrane Database Syst Rev. 2015 (6) CD009566. doi:10.1002/14651858.CD009566.pub2. hdl:2164/6048. PMC 10616535. PMID 26028608.
↑ Castells M, Butterfield J (April 2019). "Mast Cell Activation Syndrome and Mastocytosis: Initial Treatment Options and Long-Term Management". J Allergy Clin Immunol Pract. 7 (4): 1097–1106. doi:10.1016/j.jaip.2019.02.002. PMID 30961835.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
1 2 3 4 Chadwick SJ (15 Mei 2009). "Principles of Allergy Management". Managing the Allergic Patient. hlm. 19–72. doi:10.1016/B978-141603677-7.50006-6. ISBN 978-1-4160-3677-7. Sodium cromoglycate (cromolyn sodium) has now been available in an intranasal format OTC for almost 10 years[...] Nedocromil is much more potent [...] Other ophthalmic mast cell stabilizers include cromolyn sodium, ketotifen, and pemirolast, and topical antihistamines such as olopatadine also demonstrate mast-cell stabilizing effects. Cromolyn sodium is also used as an oral preparation for the treatment of mastocytosis and has been used off-label in the management of food allergy
↑ Wang Y, Liu Z, Zhou W, Wang J, Li R, Peng C, et al. (Februari 2024). "Mast cell stabilizer, an anti-allergic drug, reduces ventricular arrhythmia risk via modulation of neuroimmune interaction". Basic Res Cardiol. 119 (1): 75–91. doi:10.1007/s00395-023-01024-y. PMID 38172251.
↑ "Mast cell stabilizers". drugs.com. Diakses tanggal 2 April 2023.{{cite web}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
1 2 Zhang L, Song J, Hou X (April 2016). "Mast Cells and Irritable Bowel Syndrome: From the Bench to the Bedside". J Neurogastroenterol Motil. 22 (2): 181–92. doi:10.5056/jnm15137. PMC 4819856. PMID 26755686.{{cite journal}}: Pemeliharaan CS1: Tanggal diterjemahkan otomatis (link)
↑ Nwaru BI, Dhami S, Sheikh A (2017). "Idiopathic Anaphylaxis". Curr Treat Options Allergy. 4 (3): 312–319. doi:10.1007/s40521-017-0136-2. PMC 5569651. PMID 28890861.
↑ El-Alali EA, Abukhiran IM, Alhmoud TZ (Juli 2021). "Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review". BMC Gastroenterol. 21 (1) 279. doi:10.1186/s12876-021-01854-x. PMC 8265096. PMID 34238222.
1 2 Feuille EJ, Phipatanakul W, Permaul P (2022). "Conventional medications for the treatment of allergic rhinitis and conjunctivitis". Allergic and Immunologic Diseases. hlm. 1077–1109. doi:10.1016/B978-0-323-95061-9.00038-2. ISBN 978-0-323-95061-9. Evidence is insufficient to compare the efficacy of available ocular mast cell stabilizers (cromolyn, lodoxamide, nedocromil)
↑ Chu R, Bajaj P (2025). Asthma Medication in Children. PMID 28722853.
↑ Kowtharapu LP, Katari NK, Sandoval CA, Konduru N, Muchakayala SK, Pydimarry SP, et al. (Juni 2023). "Regulatory Perspective Reverse Engineering Analysis of the Mast Cell Stabilizer and the Histamine Receptor Antagonist (Olopatadine HCl): Instrumental and Classical Methods for Multiple Formulations". ACS Omega. 8 (24): 21485–21492. doi:10.1021/acsomega.3c00311. PMC 10285952. PMID 37360430.{{cite journal}}: Pemeliharaan CS1: DOI bebas tanpa ditandai (link)
↑ Lui ZQ, Lii XX, Qui ZQ, Yu Y, Li MG (2017). "Vitamin D contributes to mast cell stabilization". Allergy. 72 (8): 1184–1192. doi:10.1111/all.13110. PMID 27998003. S2CID 4643742.
↑ Weng Z, Zhang B, Asadi S, Sismanopoulos N, Butcher A, Fu X, et al. (28 Maret 2012). "Quercetin Is More Effective than Cromolyn in Blocking Human Mast Cell Cytokine Release and Inhibits Contact Dermatitis and Photosensitivity in Humans". PLOS ONE. 7 (3) e33805. Bibcode:2012PLoSO...733805W. doi:10.1371/journal.pone.0033805. PMC 3314669. PMID 22470478.